reAlpha Tech Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by reAlpha Tech Corp. (Nasdaq: AIRE) on October 20, 2025. The report details the exercise of various warrant classes by holders, resulting in the issuance of additional common stock and the receipt of gross proceeds. The company is incorporated in Delaware and identifies as an emerging growth company.
Key Financial Metrics
- Gross Proceeds: Approximately $8.3 million generated from warrant exercises reported as of October 20, 2025.
- Shares Issued (Current Period): 35,845,285 shares issued to warrant holders as of October 20, 2025.
- Total Shares Outstanding: 126,495,220 shares as of October 20, 2025.
- Previous Issuance: 7,291,668 shares were issued between September 11 and September 12, 2025 (previously reported).
Material Changes and Warrant Exercise Details
Between September 12, 2025, and October 15, 2025, holders exercised rights to purchase shares under four distinct warrant categories:
- Inducement Warrants: 230,000 shares at $0.75 per share (issued April 8, 2025).
- July 2025 Warrants: 21,863,616 shares at $0.15 per share (issued July 18, 2025).
- Private Placement Warrants: 10,752,859 shares at $0.35 per share (issued July 22, 2025).
- Placement Agent Warrants: 617,856 shares at $0.4375 per share (issued July 22, 2025).
The filing notes that stockholder approval for the issuance of shares underlying the July 2025 Warrants was obtained on October 8, 2025, to comply with Nasdaq Listing Rule 5635(d).
Guidance, Outlook, and Risks
The filing does not provide specific forward-looking guidance, management commentary on future operations, or a discussion of risks and contingencies beyond the regulatory compliance regarding Nasdaq listing rules. The document focuses strictly on the mechanics of the warrant exercises and the resulting capital raise.
Investor Verification Checklist
- Verify the total number of outstanding shares (126,495,220) against the company's latest 10-Q or 10-K filings to confirm dilution impact.
- Confirm the utilization of the $8.3 million in gross proceeds, as the filing does not specify the intended use of funds.
- Review the effectiveness of the Form S-3 (File No. 333-287009) and Form S-1 registrations mentioned to ensure the shares are freely tradable.
- Assess the remaining unexercised warrants from the April, July, and concurrent offerings to gauge potential future dilution.